Carcinoma, Hepatocellular: all 3,249 studies
Page 32 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT00712855Phase 1
- Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)CompletedNCT00712790Phase 1/2
- Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)Status unknownNCT00707681Phase 2
- Treatment of Unresectable Hepatocellular Cancer With Opioid Growth FactorCompletedNCT00706576Phase 1
- Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00703365Phase 2
- Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver CancerNo longer availableNCT00701168
- 11C-Acetate PET/CT Non-FDG-Avid TumorsStatus unknownNCT00687778
- TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)CompletedNCT00683631
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular CarcinomaTerminatedNCT00669136Phase 1
- Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular CarcinomaCompletedNCT00662246Phase 1
- Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular CarcinomaCompletedNCT00652587Phase 3
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisCompletedNCT00646100Phase 4
- Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) PatientsStatus unknownNCT00644020
- Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular CarcinomaCompletedNCT00635323Phase 2
- Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial ChemoembolizationCompletedNCT00630240
- Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular CarcinomaCompletedNCT00630084Phase 4
- A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic CarcinomaCompletedNCT00629759Phase 1
- Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular CarcinomaCompletedNCT00629486Not applicable
- Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective StudyCompletedNCT00629421
- Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00619541Phase 2
- TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00618384Phase 2
- Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid TumorsStatus unknownNCT00610389Phase 2
- Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
- Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCCStatus unknownNCT00606385Not applicable
- Alternative Surgical Policy for Central Liver TumorsCompletedNCT00600522
- Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma TherapyCompletedNCT00575523Phase 4
- Phase III Study of PI-88 in Post-resection Hepatocellular CarcinomaTerminatedNCT00568308Phase 3
- A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver CancerStatus unknownNCT00563095Not applicable
- Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T CellsTerminatedNCT00562666Phase 1
- Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative ResectionStatus unknownNCT00561522Phase 2/3
- Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00559455Phase 2
- Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00557024Phase 4
- TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular CarcinomaStatus unknownNCT00556803Phase 4
- Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00555334Phase 4
- Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular CarcinomaStatus unknownNCT00554905Phase 4
- Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan CriteriaStatus unknownNCT00554125Phase 3
- Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular CarcinomaCompletedNCT00534664Phase 1/2
- A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer PatientsCompletedNCT00526617Phase 1
- A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular CarcinomaCompletedNCT00524498Phase 2
- Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular CarcinomaStatus unknownNCT00522405Phase 2/3
- UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaCompletedNCT00519688Phase 2
- Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With AntiangiogenesisStatus unknownNCT00518557Not applicable
- Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00517920Phase 2
- Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels InvasionStatus unknownNCT00501813Phase 3
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- GH, IGF-I and Somatostatin Analogues in Hepatocellular CarcinomaCompletedNCT00495846Phase 2/3
- Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver TumorsCompletedNCT00493883Phase 1/2
- Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot StudyWithdrawnNCT00493428Phase 2
- Different Regimens of Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNCT00493402Phase 3
- Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00490685Phase 2
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)CompletedNCT00484211Phase 2
- Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cmCompletedNCT00479050Phase 1
- Sorafenib With TACE to Treat Hepatocellular CarcinomaCompletedNCT00478374Phase 1
- Intravascular Ultrasound for Hepatocellular Carcinoma StagingStatus unknownNCT00474734
- Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma PatientsCompletedNCT00471965Phase 3
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
- Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular CarcinomaCompletedNCT00467974Phase 3
- Protein Biomarker in Hepatocellular CarcinomaTerminatedNCT00465842
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic MetastasesCompletedNCT00465023Not applicable
- Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)CompletedNCT00464919Phase 2
- Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)CompletedNCT00464295Phase 2
- Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular CarcinomaStatus unknownNCT00460681Phase 3
- A Phase III Study in Post-operative HBV-related Hepatocellular CarcinomaTerminatedNCT00455091
- A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.CompletedNCT00444782Phase 2
- A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the LiverCompletedNCT00441376Phase 1
- A Study of Electromagnetic Waves in the Treatment of the Advanced HepatocarcinomaTerminatedNCT00440934Phase 2
- A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver DysfunctionCompletedNCT00437424Phase 1
- Proton Therapy and Bevacizumab for Primary Liver TumorsTerminatedNCT00426829Phase 1
- A Phase-II Trial of ZIO 101 in Advanced Hepatocellular CarcinomaTerminatedNCT00423306Phase 2
- A Study of LY2181308 in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT00415155Phase 1/2
- Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003TerminatedNCT00405873Phase 2
- Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver MetastasisCompletedNCT00392366Not applicable
- Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00390195Phase 1/2
- Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular CarcinomaCompletedNCT00386984Phase 3
- A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)Status unknownNCT00384800Phase 2
- Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCCCompletedNCT00375661Phase 4
- A Phase I Study of Pazopanib in Adult Patients With Liver CancerCompletedNCT00370513Phase 1
- SU011248 in Advanced Hepatocellular CarcinomaCompletedNCT00361309Phase 2
- Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCsCompletedNCT00357474Phase 3
- Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)CompletedNCT00357422Not applicable
- HAI Via Interventionally Implanted Port Catheter SystemsStatus unknownNCT00356161Phase 2
- Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular CarcinomaCompletedNCT00355862Phase 3
- A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedNCT00355355Phase 3
- Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular CarcinomaTerminatedNCT00355212Phase 3
- Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00351195Phase 2
- The Second Multicenter Hemophilia Cohort StudyCompletedNCT00341705
- Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma CellsStatus unknownNCT00327496Not applicable
- A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular CarcinomaTerminatedNCT00319683Phase 1/2
- Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00300521Phase 2
- Accuracy of Endoscopic Ultrasound for Detection of Tumors of the LiverStatus unknownNCT00290316Phase 2
- Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular CarcinomaStatus unknownNCT00282100Phase 2
- Oxaliplatin in Unresectable Hepatocellular CarcinomaCompletedNCT00280618Phase 2
- Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular CarcinomaTerminatedNCT00280007Phase 2
- Patupilone Activity in Advanced/Metastatic Hepatocellular CarcinomaCompletedNCT00273312Phase 2
- Treatment With IFN After Curative Resection of HCC in HCV-Related CirrhosisCompletedNCT00273247Phase 3
- Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead EmbolisationCompletedNCT00261378Phase 2
- Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per MicroliterCompletedNCT00250822Phase 2
- Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00250796Phase 2
- Safety of 32P BioSilicon in Patients With Hepatocellular CarcinomaStatus unknownNCT00247260Phase 2
- Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00241020Phase 3